Apalutamide in prostate cancer: indication of considerable added benefit Posted on 07/05/2019 by Mila Symptomatic progression is significantly retarded by this drug. This advantage clearly outweighs the disadvantages presented by some side effects. Source: EurekaAlert, https://www.eurekalert.org